Financing, Equity Capital Markets
Tourmaline Bio
01/24
|
$172.4 Million
Âé¶¹´«Ã½ served as bookrunner for Tourmaline Bio, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma